39 results
8-K
EX-10.1
CUE
Cue Biopharma Inc
10 Feb 20
Entry into a Material Definitive Agreement
4:01pm
or documents from Executive (other than in connection with any litigation or other proceeding in which Executive is aparty-in-opposition) with respect … the pendency of any litigation or other proceeding involving Claims, Executive shall not communicate with anyone (other than Executive’s attorneys
8-K
EX-10.2
CUE
Cue Biopharma Inc
7 Oct 19
Entry into a Material Definitive Agreement
4:42pm
information or documents from Executive (other than in connection with any litigation or other proceeding in which Executive is aparty-in-opposition … required. During the pendency of any litigation or other proceeding involving Claims, Executive shall not communicate with anyone (other than
8-K
EX-10.1
CUE
Cue Biopharma Inc
24 Aug 20
Entry into a Material Definitive Agreement
4:21pm
attempts to obtain information or documents from Executive (other than in connection with any litigation or other proceeding in which Executive … not do so unless legally required. During the pendency of any litigation or other proceeding involving Claims, Executive shall not communicate
8-K
EX-10.1
6sj4x3yk
7 Oct 19
Entry into a Material Definitive Agreement
4:42pm
10-K
aehxun9rsn7 zu4y
29 Mar 18
Annual report
12:00am
8-K
EX-99.1
hxer7vb
9 May 24
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:01pm
424B1
5d7xpmyamom9s 57lg
21 Dec 17
Prospectus with pricing info
12:00am
8-K
EX-10.1
goj 51ug43
30 Mar 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
bu5qa5ed uy
15 Nov 21
Regulation FD Disclosure
7:57am
8-K
EX-10.2
d52xvza7rn620699
15 Nov 22
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
4:30pm
8-K
EX-1.1
pol0pkt16ll2
1 Oct 21
Entry into a Material Definitive Agreement
5:01pm
10-K
EX-10.21
veiiexo2c 5biltp5enw
29 Mar 18
Annual report
12:00am